about
Dysregulation of group-I metabotropic glutamate (mGlu) receptor mediated signalling in disorders associated with Intellectual Disability and AutismThe FMRP/GRK4 mRNA interaction uncovers a new mode of binding of the Fragile X mental retardation protein in cerebellumGroup I metabotropic glutamate receptors: a role in neurodevelopmental disorders?Metabotropic glutamate receptors in glial cells.Differential patterns of NOTCH1-4 receptor expression are markers of glioma cell differentiation.Neuro-Inflammatory Mechanisms in Developmental Disorders Associated with Intellectual Disability and Autism Spectrum Disorder: A Neuro- Immune Perspective.The 3' UTR of FMR1 mRNA is a target of miR-101, miR-129-5p and miR-221: implications for the molecular pathology of FXTAS at the synapse.Fragile X mental retardation protein (FMRP) interacting proteins exhibit different expression patterns during development.A prolonged pharmacological blockade of type-5 metabotropic glutamate receptors protects cultured spinal cord motor neurons against excitotoxic death.A reduced number of metabotropic glutamate subtype 5 receptors are associated with constitutive homer proteins in a mouse model of fragile X syndrome.Altered replication timing of the HIRA/Tuple1 locus in the DiGeorge and Velocardiofacial syndromes.Endothelin-1 Induces Degeneration of Cultured Motor Neurons Through a Mechanism Mediated by Nitric Oxide and PI3K/Akt Pathway.Endothelin-1 is over-expressed in amyotrophic lateral sclerosis and induces motor neuron cell death.Activation of Serotonin 5-HT Receptors Modulates Hippocampal Synaptic Plasticity by Stimulation of Adenylate Cyclases and Rescues Learning and Behavior in a Mouse Model of Fragile X SyndromeCalcitonin Gene-Related Peptide (CGRP) Stimulates Purkinje Cell Dendrite Growth in CultureAberrant mitochondrial bioenergetics in the cerebral cortex of the Fmr1 knockout mouse model of fragile X syndrome
P50
Q33877423-09DCB238-1A8C-47AF-BAAC-086F489A15B9Q36676669-697307CF-DAC7-4B4F-B1CB-598C0D24693AQ36961196-B2D3A1CA-B71C-4BC8-9142-BEA9CA991816Q37148385-C06C8C1C-7CAE-4CE1-B162-0C016D7AA42CQ37492156-20FE6CD4-8D30-46CB-8051-8EC26FBD98A9Q38782169-1301E3CE-402F-47B6-B840-590E84FDBC2FQ41412994-A6F181A1-1208-4EAC-9A15-EA458B491911Q41436660-CE652BCB-C91B-486F-8CEC-E40038012A93Q42757881-610C4D78-F783-4963-BCF6-40B9C8C7E41FQ46726655-F7AA137F-7FDC-4C68-B32B-FCA9CD28D600Q47395427-536D7986-DFAD-418F-9380-89E13DFCB908Q48137454-663BEDFB-57A1-46F0-AEC6-AEF078F69A86Q51758658-550BF875-8B79-4464-9382-C65FC228FAB7Q58586702-768962D9-D45D-4A90-95DF-881E76651F60Q63484466-D1151443-327E-4F06-A5F7-84ACF254827FQ91189188-6FC0C981-2BEC-41D2-A861-A29197FF0C33
P50
description
researcher ORCID ID = 0000-0001-5972-8790
@en
wetenschapper
@nl
name
Simona D'Antoni
@ast
Simona D'Antoni
@en
Simona D'Antoni
@es
Simona D'Antoni
@nl
type
label
Simona D'Antoni
@ast
Simona D'Antoni
@en
Simona D'Antoni
@es
Simona D'Antoni
@nl
prefLabel
Simona D'Antoni
@ast
Simona D'Antoni
@en
Simona D'Antoni
@es
Simona D'Antoni
@nl
P106
P21
P31
P496
0000-0001-5972-8790